| First Author | Zhen G | Year | 2013 |
| Journal | Nat Med | Volume | 19 |
| Issue | 6 | Pages | 704-12 |
| PubMed ID | 23685840 | Mgi Jnum | J:198678 |
| Mgi Id | MGI:5498630 | Doi | 10.1038/nm.3143 |
| Citation | Zhen G, et al. (2013) Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19(6):704-12 |
| abstractText | Osteoarthritis is a highly prevalent and debilitating joint disorder. There is no effective medical therapy for the condition because of limited understanding of its pathogenesis. We show that transforming growth factor beta1 (TGF-beta1) is activated in subchondral bone in response to altered mechanical loading in an anterior cruciate ligament transection (ACLT) mouse model of osteoarthritis. TGF-beta1 concentrations are also high in subchondral bone from humans with osteoarthritis. High concentrations of TGF-beta1 induced formation of nestin-positive mesenchymal stem cell (MSC) clusters, leading to formation of marrow osteoid islets accompanied by high levels of angiogenesis. We found that transgenic expression of active TGF-beta1 in osteoblastic cells induced osteoarthritis, whereas inhibition of TGF-beta activity in subchondral bone attenuated the degeneration of articular cartilage. In particular, knockout of the TGF-beta type II receptor (TbetaRII) in nestin-positive MSCs led to less development of osteoarthritis relative to wild-type mice after ACLT. Thus, high concentrations of active TGF-beta1 in subchondral bone seem to initiate the pathological changes of osteoarthritis, and inhibition of this process could be a potential therapeutic approach to treating this disease. |
